Judge Travis A. (“Tag”) Greaves left me with a fascinating tidbit to spice up my Thanksgiving Day ruminations, in Amgen Inc. & Subsidiaries, Docket No. 16017-21, filed 11/22/23.

IRS moves for summary J on “HCR Fees Penalties.” Now I didn’t know what those were either, but I see that they arose under the much-contemned Affordable Care Act, more particularly bounded and described in Section 9008 of the ACA and amended by Section 1404 of the Health Care and Education Reconciliation Act of 2010.

Apparently there is some kind of fees imposed upon various drug manufacturers. But as Judge Tag Greaves has sealed all documents pertaining thereto, we are left to wonder, or surf the web and try to separate fact from whatever else is found thereon.

Amgen has been here before, jousting about discovery, but never have penalties been mentioned before now.

Are we about to get Boss Hoss on drugs?